Results 181 to 190 of about 30,781 (201)
Some of the next articles are maybe not open access.
Clopidogrel Response Variability, Resistance, or Both?
The American Journal of Cardiology, 2006Dual antiplatelet therapy represents an important advance for patients with established cardiovascular disease. Variable platelet response and potential resistance to therapy have emerged with aspirin and clopidogrel. There is no clear and accepted definition of clopidogrel resistance, but patients with lower responses to clopidogrel are at risk for ...
openaire +2 more sources
Promising clopidogrel analogs may overcome clopidogrel resistance: 2025 update
Biochemical PharmacologyClopidogrel is one of the World Health Organization-recommended essential medicines used for antiplatelet therapy. However, its usage is limited by resistance of certain patients to clopidogrel. Herein, we systematically summarized promising novel analogs of clopidogrel and evaluated their preclinical and clinical properties as well as the science ...
Hong-Guang Xie +5 more
openaire +2 more sources
Evaluation of clopidogrel resistance
Thrombosis Research, 2005Zakaria Ali, Almsherqi +3 more
openaire +2 more sources
Clopidogrel resistance / Clopidogrel-Resistenz
LaboratoriumsMedizin, 2006Tobias Geisler, Meinrad Gawaz
openaire +1 more source
[Variable extent of platelet responsiveness to clopidogrel inhibition: "clopidogrel resistance"?].
Annales de cardiologie et d'angeiologie, 2005During percutaneous coronary angioplasty, platelet inhibition by clopidogrel and aspirin has drastically decreased the risk of thrombotic occlusion of the stented vessels. However, despite the widespread use of these drugs, the incidence of acute or subacute stent thrombosis remains elevated, concerning 1 to 2% of the treated patients.
O, Morel +8 more
openaire +1 more source
Repetitive stent thrombosis in a patient who had resistance to both clopidogrel and prasugrel
Journal of Cardiology Cases, 2016Yuji Ohno, Sho Okada, Hideki Kitahara
exaly